Pharma Content Intelligence
One category, read side by side.
Two kinds of tools each solve one half of the message problem. This is the honest, category-level read of where each one stops, and where Juncture connects the content you approve to the answer a machine gives, against the same label.
00/The category
Pharma Content Intelligence
Juncture is the only pharma content intelligence platform built to connect the content you approve with the answer AI gives. Pre-check clears the asset before MLR. Answer Monitor watches ChatGPT, Gemini, Perplexity, and AI Overviews after launch. Both are measured against the same approved label.
The one-liner. The only pharma content intelligence platform built to connect pre-MLR asset checks with AI answer monitoring, both measured against the same approved label.
01/Category by category
Two categories solve one half each. Juncture joins both.
The market splits the message problem in two. One set of tools clears the content. Another set watches the answer. Read fairly, side by side, the gap is the same in both: nothing measures the content you approve against the answer a machine gives.
Inside the workflow
MLR workflow tools
Helps. Help you approve content. Review, claims, DAM and the audit trail.
Stops. They stop when the content is approved. The answer a machine gives later is out of scope.
Outside, after launch
AI answer visibility tools
Helps. Help you track AI visibility. Answers, citations and share of answer.
Stops. They do not start inside the MLR workflow, so there is no line back to the content you approved.
Both halves, one label
Juncture
Connects. Connects the approved content and the AI answer to the same label.
Both. Pre-check clears the asset before MLR. Answer Monitor watches the AI answer after launch. Both are measured against the same approved label.
Categories are described as categories. Juncture does not name vendors or assert claims about specific products. The point is structural, not competitive: approval and answer have always lived in separate tools.
01/Why we are different
Two categories. Each solves one half.
The market splits the problem in two. One set of tools clears the content. Another set watches the answer. Juncture is the only pharma content intelligence platform built to connect pre-MLR asset checks with AI answer monitoring, both measured against the same approved label.
Inside the workflow
MLR workflow tools
Solves. Review, approval, claims, DAM and the audit trail.
Misses. They stop when the content is approved.
Outside, after launch
AI answer visibility tools
Solves. Track AI answers, citations and share of answer.
Misses. They do not start inside the MLR workflow.
Both halves, one label
Juncture
Solves. Checks the asset before MLR and monitors the AI answer after launch.
And. Both are measured against the same approved label, so a pre-check verdict and a post-launch finding speak the same language.
03/The join
Most platforms solve one side.
Juncture joins both.
The work before MLR and the watch after launch are usually two products with two vocabularies. Juncture runs them as one, against a single source of truth.
A · Before MLR
Clear the asset
- Asset
- Claim
- Figure
- Visual
- Reuse
- Fair balance
- ISI
- Off-label check
B · Source of truth
One label, both halves
- The approved label
- Approved modules
Every check on the left and every finding on the right is measured against this. The before and the after speak one language.
C · After launch
Watch the answer
- ChatGPT
- Gemini
- Perplexity
- AI Overviews
- Share of Answer
- Missing claim
- Off-label drift
See the join on your brand
Compare the two halves, joined, on a real asset.
If you already run MLR tools and AI visibility dashboards, Juncture connects the gap between them. Bring an asset and a brand, and we will pre-check the asset against the label and show how the machine answers about the brand today, both measured against the same approved label.